Struct (Structure)
Oxymorphone Hydrochloride Tablet
Product Images NDC 63629-1926
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Oxymorphone Hydrochloride (NDC 63629-1926). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Table 2 (Table 2)
This text appears to be discussing the potential interactions and risks associated with the consumption of alcohol, benzodiazepines, central nervous system depressants, serotonergic drugs, muscle relaxants, and diuretics while taking oxymorphone hydrochloride tablets. It provides recommendations for monitoring patients for signs of respiratory depression and adjusting dosages as necessary. The text also mentions the potential for reduced efficacy of diuretics and increased risk of urinary retention or constipation when taking oxyomorphone hydrochloride tablets with anticholinergic drugs.*
Table 1 (Table 1)
The text provides a table of adverse reactions reported in placebo-controlled trials of Oxymorphone Hydrochloride Tablets, including the percentage of patients with each reaction. The table includes reactions such as nausea, pyrexia, somnolence, vomiting, pruritus, headache, dizziness, constipation, and confusion.*
Table 3 (Table 3)
The table shows the mean values of oxymorphone hydrochloride tablets' pharmacokinetic parameters for different dosages in single and multiple doses. The parameters include C, Auc, and T. The 5mg dose resulted in a C range of 1.10-1.73 ng/mL, Auc range of 4.48-4.63 ng-hr/mL, and T range of 7.25-NA. For the 10mg dose, the C range was 1.93-3.51 ng/mL, Auc range was 9.10-10.19 ng-hr/mL, and T range was 7.78-NA. The 20mg dose had C range 4.39-7.33 ng/mL, Auc range of 20.07-21.10 ng-hr/mL, and T range of 9.43-NA. The last column, T, was not available for multiple doses. These results were obtained after five days of every 6-hour dosing.*
Label (Lbl636291926)
This text describes a medication called "Oxymorphone Hydrochloride Tablets," which contains 5mg of oxymorphone hydrochloride. It is important to keep the medication out of reach of children and store it at room temperature. The medication should be dispensed in a tightly sealed, light-resistant container with a child-resistant closure. There is a risk of overdose and addiction with the medication, and it requires a prescription. The NDC number is 63629-1926-1 and each bottle contains 100 tablets.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
